Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs77375493
rs77375493
JAK2 ; INSL6
0.900 GeneticVariation UNIPROT None of the AML patients with the JAK2 V617F mutation had a history of previous hematologic disorders. 16247455

2006
dbSNP: rs121912472
rs121912472
JAK2 ; INSL6
0.810 GeneticVariation UNIPROT Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. 23970018

2013
dbSNP: rs121912472
rs121912472
JAK2 ; INSL6
0.810 GeneticVariation UNIPROT The JAK2 V617F mutation in de novo acute myelogenous leukemias. 16247455

2006
dbSNP: rs121912472
rs121912472
JAK2 ; INSL6
0.810 GeneticVariation UNIPROT NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology. 22138009

2011
dbSNP: rs121913487
rs121913487
FLT3
0.800 GeneticVariation UNIPROT

dbSNP: rs28931590
rs28931590
CEBPA ; CEBPA-DT
0.800 GeneticVariation UNIPROT Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. 11242107

2001
dbSNP: rs28931590
rs28931590
CEBPA ; CEBPA-DT
0.800 GeneticVariation UNIPROT Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2. 12661007

2003
dbSNP: rs28931590
rs28931590
CEBPA ; CEBPA-DT
0.800 GeneticVariation UNIPROT Mutation of CEBPA in familial acute myeloid leukemia. 15575056

2004
dbSNP: rs28931590
rs28931590
CEBPA ; CEBPA-DT
0.800 GeneticVariation UNIPROT NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology. 22138009

2011
dbSNP: rs28931590
rs28931590
CEBPA ; CEBPA-DT
0.800 GeneticVariation UNIPROT Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. 23970018

2013
dbSNP: rs1169288572
rs1169288572
SETD2
0.700 GeneticVariation UNIPROT

dbSNP: rs1466524306
rs1466524306
GPR183 ; UBAC2
0.700 GeneticVariation UNIPROT

dbSNP: rs267607040
rs267607040
SETBP1
0.700 GeneticVariation UNIPROT SETBP1 mutation analysis in 944 patients with MDS and AML. 23648668

2013
dbSNP: rs267607040
rs267607040
SETBP1
0.700 GeneticVariation UNIPROT Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression. 23889083

2013
dbSNP: rs569067880
rs569067880
TET2 ; TET2-AS1
0.700 GeneticVariation UNIPROT

dbSNP: rs754921650
rs754921650
SETD2
0.700 GeneticVariation UNIPROT Identification of functional cooperative mutations of SETD2 in human acute leukemia. 24509477

2014
dbSNP: rs754921650
rs754921650
SETD2
0.700 GeneticVariation UNIPROT Solution structure of the Set2-Rpb1 interacting domain of human Set2 and its interaction with the hyperphosphorylated C-terminal domain of Rpb1. 16314571

2005
dbSNP: rs10000770
rs10000770
INPP4B
C 0.700 GeneticVariation GWASCAT Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia. 27903959

2017
dbSNP: rs10001414
rs10001414
PALLD
A 0.700 GeneticVariation GWASCAT Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia. 27903959

2017
dbSNP: rs10002854
rs10002854
SORCS2
C 0.700 GeneticVariation GWASCAT Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia. 27903959

2017
dbSNP: rs10004892
rs10004892 		C 0.700 GeneticVariation GWASCAT Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia. 27903959

2017
dbSNP: rs10006108
rs10006108 		C 0.700 GeneticVariation GWASCAT Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia. 27903959

2017
dbSNP: rs10006418
rs10006418
INPP4B
A 0.700 GeneticVariation GWASCAT Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia. 27903959

2017
dbSNP: rs10010954
rs10010954
LRBA
C 0.700 GeneticVariation GWASCAT Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia. 27903959

2017
dbSNP: rs10011263
rs10011263
ANK2
G 0.700 GeneticVariation GWASCAT Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia. 27903959

2017